Arylpiperazine derivatives acting at 5-HT1A receptors

被引:154
作者
López-Rodríguez, ML [1 ]
Ayala, D [1 ]
Benhamù, B [1 ]
Morcillo, MJ [1 ]
Viso, A [1 ]
机构
[1] Univ Complutense, Fac Ciencias Quim, Dept Quim Organ 1, E-28040 Madrid, Spain
关键词
D O I
10.2174/0929867023371030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists. Among 5-HTRs, the 5-HT1A subtype is the best studied and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression. Several structurally different compounds are known to bind 5-HT1AR sites. Among these, arylpiperazine derivatives represent one of the most important classes of 5HT(1A)R ligands. This article will review the development of arylpiperazine derivatives acting at 5-HT(1A)Rs with an emphasis on structure-affinity relationships of agonists and antagonists, ligand-receptor interactions and pharmacological applications.
引用
收藏
页码:443 / 469
页数:27
相关论文
共 253 条
  • [1] Abi-Dargham A, 1996, DRUG TODAY, V32, P171
  • [2] Synthesis and SAR of adatanserin:: Novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents
    Abou-Gharbia, MA
    Childers, WE
    Fletcher, H
    McGaughey, G
    Patel, U
    Webb, MB
    Yardley, J
    Andree, T
    Boast, C
    Kucharik, RJ
    Marquis, K
    Morris, H
    Scerni, R
    Moyer, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) : 5077 - 5094
  • [3] POLYCYCLIC ARYLPIPERAZINYL AND HETEROARYLPIPERAZINYL IMIDES AS 5-HT1A RECEPTOR LIGANDS AND POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES
    ABOUGHARBIA, M
    PATEL, UR
    WEBB, MB
    MOYER, JA
    ANDREE, TH
    MUTH, EA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (07) : 1382 - 1392
  • [4] SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIP OF SUBSTITUTED TETRAHYDRO AND HEXAHYDRO-1,2-BENZISOTHIAZOL-3-ONE 1,1-DIOXIDES AND THIADIAZINONES - POTENTIAL ANXIOLYTIC AGENTS
    ABOUGHARBIA, M
    MOYER, JA
    PATEL, U
    WEBB, M
    SCHIEHSER, G
    ANDREE, T
    HASKINS, JT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (05) : 1024 - 1033
  • [5] PRECLINICAL PHARMACOLOGY OF FG5893 - A POTENTIAL ANXIOLYTIC DRUG WITH HIGH-AFFINITY FOR BOTH 5-HT1A AND 5-HT2A RECEPTORS
    ALBINSSON, A
    BJORK, A
    SVARTENGREN, J
    KLINT, T
    ANDERSSON, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (03) : 285 - 294
  • [6] Mapping the binding site pocket of the serotonin 5-hydroxytryptamine(2A) receptor - Ser(3.36(159)) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin
    Almaula, N
    Ebersole, BJ
    Zhang, DQ
    Weinstein, H
    Sealfon, SC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) : 14672 - 14675
  • [7] Ambrosio C, 2000, MOL PHARMACOL, V57, P198
  • [8] EFFECTS OF FG-5893, A NEW COMPOUND WITH 5-HT1A RECEPTOR AGONISTIC AND 5-HT2 RECEPTOR ANTAGONISTIC PROPERTIES, ON MALE-RAT SEXUAL-BEHAVIOR
    ANDERSSON, G
    LARSSON, K
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 255 (1-3) : 131 - 137
  • [9] [Anonymous], MED CHEM RES
  • [10] PILOT-STUDY OF FLESINOXAN, A 5-HT1A AGONIST, IN MAJOR DEPRESSION - EFFECTS ON SLEEP REM LATENCY AND BODY-TEMPERATURE
    ANSSEAU, M
    PITCHOT, W
    MORENO, AG
    WAUTHY, J
    PAPART, P
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1993, 8 (04) : 279 - 283